| Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma (NCT06365619) | University of Utah | 2026-07-01 |
| Predicting Response to Naltrexone With Eye Tracking in Gaming Disorder (NCT04649892) | University of Sao Paulo | 2026-07-01 |
| A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis (NCT07660848) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2026-07-01 |
| High-Protein Diet for Improving Alcoholic Fatty Liver Disease (NCT07632222) | Li Lab,MD | 2026-07-01 |
| Combination of CXD and Restrictive Ketogenic Diet Against MASLD (NCT07639866) | Shanghai Municipal Hospital of Traditional Chinese Medicine | 2026-07-01 |
| A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004) (NCT07614984) | Merck Sharp & Dohme LLC | 2026-06-30 |
| Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis (NCT07728201) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2026-06-30 |
| A Multicenter, Open-label, Non-randomized, Single-arm Phase 1/2 Study of Autologous Nano CD5-CAR T Cells for the Treatment of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma (NCT07678307) | Institute of Hematology & Blood Diseases Hospital, China | 2026-06-30 |
| HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer (NCT06595563) | Jules Bordet Institute | 2026-06-30 |
| Treatment of Low-flow Vascular Malformations With Bleomycin Electrosclerotherapy (BEST) (NCT07579962) | Institute of Oncology Ljubljana | 2026-06-30 |
| Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia (NCT07323095) | Atom Therapeutics Co., Ltd | 2026-06-30 |
| Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis (NCT07679893) | Mannkind Corporation | 2026-06-30 |
| Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer (NCT07627620) | Hunan Cancer Hospital | 2026-06-30 |
| Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC (NCT07489066) | Pfizer | 2026-06-30 |
| A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE) (NCT07564596) | Climb Bio, Inc. | 2026-06-30 |
| To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment (NCT07684820) | Expedition Therapeutics, Inc | 2026-06-30 |
| FG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade Glioma (NCT07609472) | FluoGuide A/S | 2026-06-30 |
| A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight (NCT07662122) | Boehringer Ingelheim | 2026-06-30 |
| Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK202 for Injection in Combination With Drugs in NSCLC Participants. (NCT07603791) | Shanghai Allink Biotherapeutics Co., Ltd. | 2026-06-30 |
| Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF) (NCT07161843) | Ebima Clifford Okundaye | 2026-06-30 |
| A Phase II Study to Evaluate the Efficacy and Safety of SYH2059 Tablets in Adult Patients With Idiopathic Pulmonary Fibrosis (NCT07600021) | InnovStone Therapeutics Limited | 2026-06-30 |
| A Phase II Study of PD-1/IL-2α-bias Bispecific Antibody Fusion Protein Monotherapy in Advanced Esophageal Squamous Cell Carcinoma After Failure of Prior ICI Plus Platinum-Based Chemotherapy (NCT07688291) | Beijing GoBroad Hospital | 2026-06-30 |
| A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes (NCT07658560) | BrightGene Bio-Medical Technology Co., Ltd. | 2026-06-30 |
| Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab (NCT07751042) | Strand Therapeutics Inc. | 2026-06-30 |
| A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations (NCT07514858) | H. Lundbeck A/S | 2026-06-30 |
| 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer (NCT04529044) | OHSU Knight Cancer Institute | 2026-06-30 |
| SCTB41 Plus SCTB39G With or Without Standard Therapy in Advanced Solid Tumors (NCT07665970) | Sinocelltech Ltd. | 2026-06-30 |
| AI-Driven Treatment Strategy vs ZR2 in Older Treatment-naive Patients With LBCL (NCT07717177) | Ruijin Hospital | 2026-06-30 |
| Oral N-acetylglucosamine in Crohn's Disease (NCT07225998) | Johns Hopkins University | 2026-06-30 |
| A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus (NCT07694336) | Victoria Werth | 2026-06-30 |
| The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma (NCT07386002) | T-MAXIMUM Pharmaceutical Inc | 2026-06-30 |
| EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety (NCT07523581) | Eloxx Pharmaceuticals, Inc. | 2026-06-30 |
| Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia (NCT07714512) | Institute of Hematology & Blood Diseases Hospital, China | 2026-06-30 |
| This Study Evaluates the Safety, Target Engagement, and Preliminary Efficacy of Galunisertib (TGF-βR1/ALK5 Inhibitor)Combined With Nerandomilast (PDE4 Inhibitor) in GREM2-positive ALS, a Biomarker-defined Subgroup Hypothesized to Reflect Heightened TGF-β/SMAD-driven Astrocytic and Fibrotic Signaling (NCT07321860) | Gipfel Life Sciences GmbH | 2026-06-30 |
| SKB315 in Combination Therapy in Patients With Advanced or Metastatic GC/ GEJ Adenocarcinoma (NCT07609667) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-06-30 |
| A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma (NCT07589634) | Janssen Research & Development, LLC | 2026-06-30 |
| [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications (NCT07702292) | Blue Earth Diagnostics | 2026-06-30 |
| Enhancing Smoking Cessation for African American People Everywhere (NCT07024992) | University of Houston | 2026-06-30 |
| Serplulimab Plus Decitabine and CAPOX Before Surgery for Locally Advanced Colorectal Cancer (NCT07691632) | Tianjin Medical University Cancer Institute and Hospital | 2026-06-30 |
| Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted Therapy (NCT07684950) | Henan Cancer Hospital | 2026-06-30 |
| Periprosthetic Joint Infection Bubble Study (NCT07599865) | Thomas Jefferson University | 2026-06-30 |
| MDMA Therapy in Veterans With PTSD (NCT07569159) | Sunstone Medical | 2026-06-30 |
| Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-type Metastatic Colorectal Cancer (NCT07683403) | Fudan University | 2026-06-30 |
| Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy (NCT07663422) | Fox Chase Cancer Center | 2026-06-30 |
| A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma (NCT07678684) | HighField Biopharmaceuticals Corporation | 2026-06-30 |
| Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors (NCT07570966) | Novartis Pharmaceuticals | 2026-06-30 |
| Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease (NCT07005180) | Hillhurst Biopharmaceuticals, Inc. | 2026-06-30 |
| AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study) (NCT07640737) | Aurigene Discovery Technologies Limited | 2026-06-30 |
| PD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma (NCT07641010) | Shanghai Jiao Tong University School of Medicine | 2026-06-30 |
| Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer (NCT07358689) | Tianjin Medical University Cancer Institute and Hospital | 2026-06-30 |
| HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma (NCT07685535) | Shanghai Zhongshan Hospital | 2026-06-30 |
| Kumorixilib Plus Capecitabine and Letrozole for Neoadjuvant Treatment of HR-Positive HER2-Negative Breast Cancer (NCT07691333) | Fujian Cancer Hospital | 2026-06-30 |
| Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML (NCT07643636) | Dongguan People's Hospital | 2026-06-30 |
| A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) (NCT07581002) | AbbVie | 2026-06-30 |
| A Clinical Study of ZL-85FA Tablets (NCT07339748) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2026-06-30 |
| Fluzoparib + Bevacizumab vs Olaparib + Bevacizumab for Maintenance Therapy in HRD-Positive Advanced Ovarian Cancer (NCT07647653) | Shandong University | 2026-06-30 |
| ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer (NCT07452224) | iLeukon Therapeutics, Inc. | 2026-06-29 |
| AMT-116 in Combination With AK112 in Patients With Lung Cancer (NCT07590531) | Multitude Therapeutics Inc. | 2026-06-29 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 Following Intravenous Administration in Participants With Chronic Spontaneous Urticaria (CSU) (NCT07717905) | Bambusa Therapeutics | 2026-06-29 |
| A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant (NCT07508787) | Nefro Avillion Clinical Development, LLC | 2026-06-29 |
| JS207 a Bispecific Antibody Against PD1-VEGF in Nasopharyngeal Carcinoma (NCT07690787) | Chinese University of Hong Kong | 2026-06-29 |
| A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis. (NCT07547995) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-06-29 |
| Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement (NCT07487246) | Rush University Medical Center | 2026-06-29 |
| A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis (NCT07643766) | Enveda Therapeutics | 2026-06-29 |
| Lidocaine Patch vs Intradermal Lidocaine for Epidural Needle Insertion Pain (NCT07700108) | Ohio State University | 2026-06-29 |
| Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCC (NCT07572864) | West China Hospital | 2026-06-29 |
| Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC (NCT06881823) | Novartis Pharmaceuticals | 2026-06-29 |
| Optimizing Ancillary Therapies With Immune Checkpoint Inhibitors for Solid Tumors (OAT ICI) (NCT07661459) | Val Adams | 2026-06-26 |
| Phase II Study of QLC2519 in Pediatric Solid Tumor Participants (NCT07724756) | Qilu Pharmaceutical Co., Ltd. | 2026-06-26 |
| A First-in-Human Study of HP-002 for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (NCT07658352) | Shanghai Helioson Pharmaceutical Co., Ltd. | 2026-06-26 |
| Mindful Walking Neural Correlates of Executive Function in SC Older Adults at Risk of Dementias (NCT07638046) | University of South Carolina | 2026-06-26 |
| Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab (NCT07039422) | Novartis Pharmaceuticals | 2026-06-26 |
| Phase 1b/2: Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed Myeloma (NCT07601100) | Dana-Farber Cancer Institute | 2026-06-26 |
| A Pilot Superiority Study Comparing the Efficacy of a Combination of a Glenohumeral Intra-articular Injection With a Suprascapular Nerve Block Versus a Glenohumeral Intra-articular Corticosteroid Injection in Retractile Capsulitis (NCT07680504) | Nantes University Hospital | 2026-06-25 |
| Safety and Efficacy of SUM-191 for Patients With Bacterial Conjunctivitis (NCT07565103) | Senju USA, Inc. | 2026-06-25 |
| Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV (NCT07040319) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-06-25 |
| Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy (NCT07721025) | Lexeo Therapeutics | 2026-06-25 |
| A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain (NCT07641517) | Eli Lilly and Company | 2026-06-25 |
| Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+ (NCT06210854) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-06-25 |
| Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection) (NCT07282457) | Zhongmou Therapeutics | 2026-06-25 |
| 18F-grazy-02 PET/CT of Granzyme B Expression for Monitoring Immunotherapy (NCT07724535) | Peking University Cancer Hospital & Institute | 2026-06-24 |
| A Study of AZD0292 in Chinese Participants With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization (NCT07774403) | AstraZeneca | 2026-06-24 |
| Vortioxetine for Newly Diagnosed Glioblastoma (NCT07284628) | University of Zurich | 2026-06-24 |
| Combined Gastrointestinal Decontamination in Acute Severe Poisoning (NCT07201311) | Assistance Publique - Hôpitaux de Paris | 2026-06-24 |
| Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Stem Cells Transplantation Recipients (NCT07771855) | Hopital Foch | 2026-06-24 |
| A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis (NCT07224672) | GlaxoSmithKline | 2026-06-24 |
| Study of AHB-171 in Chronic Hepatitis B Participants (NCT07630727) | Ausper Biopharma Co., Ltd. | 2026-06-24 |
| Pilot Randomized Control Trial Comparing Oral Ketamine and Oral Oxycodone for Pain Control in Emergency Department Patients (NCT07670507) | Albany Medical College | 2026-06-24 |
| Nodal-Region Sparing Short-Course RT With Chemo-PD-1/Bevacizumab vs. Short-Course RT With Chemotherapy as TNT in pMMR/MSS Locally Advanced Rectal Cancer (NCT07674732) | Dechang Diao | 2026-06-24 |
| YH02 Injection for Intra-tumor Injection Therapy in Advanced Solid Tumors With Unresponsive or Failure-Treated Cases (NCT07697937) | Tianjin First Central Hospital | 2026-06-23 |
| KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line) (NCT07406633) | Kumquat Biosciences Inc. | 2026-06-23 |
| A Study of MZE782 in Adults With PKU (NCT07694440) | Maze Therapeutics | 2026-06-23 |
| Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus (NCT06732388) | National Cancer Institute (NCI) | 2026-06-23 |
| A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21) (NCT07302347) | Merck Sharp & Dohme LLC | 2026-06-23 |
| A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies. (NCT07389239) | University of Chicago | 2026-06-23 |
| A Placebo-controlled Trial of Folinic Acid in Children With ASD (NCT07642661) | Prof. Adi Aran | 2026-06-23 |
| Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension (NCT07511361) | Kardigan, Inc. | 2026-06-23 |
| IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage (NCT07054801) | Daniel Raper, MBBS | 2026-06-23 |
| Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas (NCT07468136) | Mayo Clinic | 2026-06-23 |
| Flash Radiotherapy for Skin Cancer (NCT07455331) | Jules Bordet Institute | 2026-06-23 |